One event. Multiple sources.
Technology

We’re still figuring out the side effects of GLP-1 weight-loss drugs

1 publisher first detected 2% of 44 Technology publishers

Headline as filed by MIT Technology Review.

Compare coverage — 1 report

Every publisher that filed on this event, earliest first, with each one's headline, summary, times and how long after the first report they filed.
Publisher Headline Summary Published Detected Delay Source Status
MIT Technology Review We’re still figuring out the side effects of GLP-1 weight-loss drugs
This week my colleague Antonio Regalado had an interesting update on GLP-1 weight-loss drugs. According to research presented at an aging meeting in Boston, these drugs seem to affect at least some me
0m technologyreview.com First

Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.

Reader comments

Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.

Nobody has commented on this story yet.

Add a comment

Up to 2,000 characters. Links are not accepted. Blank lines separate paragraphs.

In this story
June and Boston 18

Related coverage

connected by shared subjects